UnitedHealth Group Incorporated (NYSE:UNH – Get Free Report)’s stock price rose 1.8% during trading on Tuesday. The company traded as high as $406.72 and last traded at $404.8790. 4,443,396 shares changed hands during trading, a decline of 38% from the average session volume of 7,213,303 shares. The stock had previously closed at $397.62.
Top UnitedHealth Group Stories
These are some of the UNH stories that stood out recently:
- Positive Sentiment: UnitedHealth raised its 2026 adjusted EPS outlook for the third time this year, to at least $20.50 from at least $17.75 in January. Optum Health’s third-quarter operating earnings also improved substantially year over year, supporting the turnaround narrative. UnitedHealth Just Raised Guidance for the Third Time This Year
- Negative Sentiment: UnitedHealth plans to drop Medicare plans in 140 counties and leave Wyoming, a potential headwind to membership and revenue in affected markets. UnitedHealth Group Will Drop Medicare Plans in 140 Counties and Leave Wyoming
- Neutral Sentiment: A law firm is soliciting shareholders regarding possible fiduciary-duty claims. The announcement is an invitation to contact the firm, not evidence that misconduct occurred or that a claim has merit. Shareholder Rights and Fiduciary-Duty Inquiry
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on UNH shares. Argus increased their target price on UnitedHealth Group from $400.00 to $470.00 and gave the stock a “buy” rating in a report on Monday, July 20th. JPMorgan Chase & Co. boosted their price target on UnitedHealth Group from $516.00 to $524.00 and gave the company an “overweight” rating in a report on Friday, October 16th. Raymond James Financial reaffirmed an “outperform” rating and set a $450.00 price objective on shares of UnitedHealth Group in a research report on Thursday, October 15th. Stephens set a $500.00 price objective on UnitedHealth Group in a report on Friday, October 16th. Finally, Cantor Fitzgerald boosted their target price on UnitedHealth Group from $440.00 to $495.00 and gave the company an “overweight” rating in a research note on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $463.93.
UnitedHealth Group Price Performance
The stock has a market cap of $363.30 billion, a price-to-earnings ratio of 23.16, a price-to-earnings-growth ratio of 1.47 and a beta of 0.51. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.74 and a current ratio of 0.74. The company has a 50-day simple moving average of $391.12 and a two-hundred day simple moving average of $364.76.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 earnings per share for the quarter, beating the consensus estimate of $4.14 by $0.55. The business had revenue of $112.72 billion during the quarter, compared to analysts’ expectations of $111.31 billion. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The firm’s revenue was down .4% on a year-over-year basis. During the same period last year, the business earned $2.59 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 20.61 EPS for the current year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Monday, December 7th will be paid a $2.32 dividend. The ex-dividend date is Monday, December 7th. This represents a $9.28 annualized dividend and a yield of 2.3%. UnitedHealth Group’s dividend payout ratio is currently 53.00%.
Insider Activity
In other news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total value of $455,910.00. Following the completion of the sale, the chief executive officer directly owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. 0.19% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in the business. Nvwm LLC increased its holdings in shares of UnitedHealth Group by 89.2% in the third quarter. Nvwm LLC now owns 70 shares of the healthcare conglomerate’s stock valued at $26,000 after purchasing an additional 33 shares during the last quarter. Wellington Altus USA Inc. boosted its holdings in shares of UnitedHealth Group by 97.1% during the 2nd quarter. Wellington Altus USA Inc. now owns 67 shares of the healthcare conglomerate’s stock worth $28,000 after buying an additional 33 shares during the period. Security National Bank of SO Dak acquired a new position in UnitedHealth Group in the 2nd quarter valued at about $29,000. Compass Wealth Management LLC acquired a new position in UnitedHealth Group in the 3rd quarter valued at about $29,000. Finally, Aberdeen Wealth Management LLC bought a new position in UnitedHealth Group in the 2nd quarter valued at about $31,000. 87.86% of the stock is owned by institutional investors and hedge funds.
About UnitedHealth Group
UnitedHealth Group is a diversified health care company that provides health benefits and health services through two main businesses: UnitedHealthcare and Optum. UnitedHealthcare offers health insurance and related benefit plans to individuals, employers and government programs, including Medicare and Medicaid. Optum provides services across the health care system, including care delivery, pharmacy services, pharmacy benefit management, health technology and data analytics. Its businesses serve consumers, health care providers, employers, health plans and government organizations.
Read More
- Five stocks we like better than UnitedHealth Group
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
- Midterm Fallout, NVIDIA Turmoil, Anthropic’s IPO: Is Broadcom a Steal?
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
